As investment and innovation reshape the animal health industry, companies are increasingly turning to sophisticated deal-making strategies to fund growth and manage risk. In a recent webinar, Venable attorneys Jim Nelson and Chuck Morton examined how businesses across therapeutics, veterinary services, nutrition, and devices are leveraging partnerships, financing, and mergers and acquisitions (M&A) to compete in a complex and expanding market. Drawing on real-world examples, the speakers outlined how capital structure and strategic planning are becoming as critical as scientific advancement in determining success.
Strategic Frameworks for Growth
Nelson described the core decision-making framework, noting partnering, finance, and M&A as three primary levers for growth. He explained that "a lot of what Chuck and I do with our clients is early-stage strategy… thinking through what we're trying to accomplish and what's available on the business landscape, financing, and other companies to partner with." He described how partnering is especially relevant in therapeutics and devices, where high research costs and uncertainty make risk-sharing essential. Morton reinforced the importance of keeping the structure of partnerships simple, saying, "anything you can do to minimize the complexity makes good sense," while acknowledging that more complex arrangements may be necessary to support innovation.
Financing and Capital Strategy Across Animal Health Segments
The speakers detailed multiple funding pathways, from venture capital to debt, depending on a company's stage and risk profile. Morton explained that early-stage innovation often requires outside investment, stating, "you're looking at venture or even growth equity, where generally you're going to be clearly giving up some equity in the business." He also pointed to private equity's role in scaling fragmented markets, particularly veterinary services, where consolidation strategies are common. Both speakers stressed that no single approach fits all scenarios, reinforcing the need for flexible capital strategies tailored to specific verticals.
M&A Trends and Industry Evolution
Mergers and acquisitions were presented as a critical tool for accelerating growth, expanding capabilities, and entering new markets. Morton described the strategic value of acquisitions, explaining that "M&A can be a great strategy because you can have rapid entry into new market segments," particularly in fragmented industries. Nelson pointed to shifting trends in animal nutrition and therapeutics, saying, "the nutrition area is starting to get a little bit more specified, higher margin-type things compared to what the historical views have been." They concluded that increasing specialization, investor activity, and changing consumer behavior are reshaping deal making across the animal health industry.
To learn more about our Animal Health Group, click here.